Physician profile
Ann E Roberts
NPI 1437145695
$1,522.41
in general payments reported to CMS, 2019-2025
17 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,117 · 2020: $238 · 2022: $47.88 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $119.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $304.44 | 2019-2020 | |
| Novo Nordisk INC | $266.52 | 2019-2025 | Ozempic |
| Amgen INC. | $243.36 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $132.41 | 2019-2020 | |
| Pfizer INC. | $124.22 | 2019 | |
| Amarin Pharma, INC. | $114.28 | 2019-2020 | |
| Allergan, INC. | $67.78 | 2019-2020 | |
| Esperion Therapeutics, INC. | $47.88 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.95 | 2019-2020 | |
| Astellas Pharma US INC | $33.92 | 2019 | |
| Janssen Pharmaceuticals, INC | $29.03 | 2020 | |
| Glaxosmithkline, LLC. | $25.91 | 2019 | |
| Merck Sharp & Dohme LLC | $24.18 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $20.80 | 2019 | |
| Ironshore Pharmaceuticals INC. | $16.07 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.13 | 2019 | |
| Flowonix Medical Incorporated | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.